These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

245 related items for PubMed ID: 15850791

  • 1. Molecular and structural characterization of fluorescent human parvovirus B19 virus-like particles.
    Gilbert L, Toivola J, White D, Ihalainen T, Smith W, Lindholm L, Vuento M, Oker-Blom C.
    Biochem Biophys Res Commun; 2005 Jun 03; 331(2):527-35. PubMed ID: 15850791
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Assembly of fluorescent chimeric virus-like particles of canine parvovirus in insect cells.
    Gilbert L, Toivola J, Lehtomäki E, Donaldson L, Käpylä P, Vuento M, Oker-Blom C.
    Biochem Biophys Res Commun; 2004 Jan 23; 313(4):878-87. PubMed ID: 14706624
    [Abstract] [Full Text] [Related]

  • 4. Disassembly of structurally modified viral nanoparticles: characterization by fluorescence correlation spectroscopy.
    Toivola J, Gilbert L, Michel P, White D, Vuento M, Oker-Blom C.
    C R Biol; 2005 Dec 23; 328(12):1052-6. PubMed ID: 16314283
    [Abstract] [Full Text] [Related]

  • 5. [Preparation of human parvovirus B19 virus-like particles].
    Zou X, Dong L, Song J, Qu J, Yu X, Lu Z, Hong T.
    Sheng Wu Gong Cheng Xue Bao; 2009 Apr 23; 25(4):575-9. PubMed ID: 19637634
    [Abstract] [Full Text] [Related]

  • 6. Visualization of the externalized VP2 N termini of infectious human parvovirus B19.
    Kaufmann B, Chipman PR, Kostyuchenko VA, Modrow S, Rossmann MG.
    J Virol; 2008 Aug 23; 82(15):7306-12. PubMed ID: 18508892
    [Abstract] [Full Text] [Related]

  • 7. Unique region of the minor capsid protein of human parvovirus B19 is exposed on the virion surface.
    Rosenfeld SJ, Yoshimoto K, Kajigaya S, Anderson S, Young NS, Field A, Warrener P, Bansal G, Collett MS.
    J Clin Invest; 1992 Jun 23; 89(6):2023-9. PubMed ID: 1376332
    [Abstract] [Full Text] [Related]

  • 8. Parvovirus B19 VP2-proteins produced in Saccharomyces cerevisiae: comparison with VP2-particles produced by baculovirus-derived vectors.
    Lowin T, Raab U, Schroeder J, Franssila R, Modrow S.
    J Vet Med B Infect Dis Vet Public Health; 2005 Jun 23; 52(7-8):348-52. PubMed ID: 16316399
    [Abstract] [Full Text] [Related]

  • 9. Chimeric parvovirus B19 capsids for the presentation of foreign epitopes.
    Brown CS, Welling-Wester S, Feijlbrief M, Van Lent JW, Spaan WJ.
    Virology; 1994 Feb 23; 198(2):477-88. PubMed ID: 7507280
    [Abstract] [Full Text] [Related]

  • 10. Construction of protein-functionalized virus-like particles of parvovirus B19.
    Bustos-Jaimes I, Soto-Román RA, Gutiérrez-Landa IA, Valadez-García J, Segovia-Trinidad CL.
    J Biotechnol; 2017 Dec 10; 263():55-63. PubMed ID: 28935566
    [Abstract] [Full Text] [Related]

  • 11. T-helper cell-mediated interferon-gamma, interleukin-10 and proliferation responses to a candidate recombinant vaccine for human parvovirus B19.
    Franssila R, Hedman K.
    Vaccine; 2004 Sep 09; 22(27-28):3809-15. PubMed ID: 15315862
    [Abstract] [Full Text] [Related]

  • 12. Monitoring human parvovirus B19 virus-like particles and antibody complexes in solution by fluorescence correlation spectroscopy.
    Toivola J, Michel PO, Gilbert L, Lahtinen T, Marjomäki V, Hedman K, Vuento M, Oker-Blom C.
    Biol Chem; 2004 Jan 09; 385(1):87-93. PubMed ID: 14977050
    [Abstract] [Full Text] [Related]

  • 13. Biological and immunological relations among human parvovirus B19 genotypes 1 to 3.
    Ekman A, Hokynar K, Kakkola L, Kantola K, Hedman L, Bondén H, Gessner M, Aberham C, Norja P, Miettinen S, Hedman K, Söderlund-Venermo M.
    J Virol; 2007 Jul 09; 81(13):6927-35. PubMed ID: 17409158
    [Abstract] [Full Text] [Related]

  • 14. Engineering of SV40-based nano-capsules for delivery of heterologous proteins as fusions with the minor capsid proteins VP2/3.
    Inoue T, Kawano MA, Takahashi RU, Tsukamoto H, Enomoto T, Imai T, Kataoka K, Handa H.
    J Biotechnol; 2008 Mar 20; 134(1-2):181-92. PubMed ID: 18243389
    [Abstract] [Full Text] [Related]

  • 15. Green fluorescent protein - Tagged HCV non-enveloped capsid like particles: development of a new tool for tracking HCV core uptake.
    Katsarou K, Serti E, Tsitoura P, Lavdas AA, Varaklioti A, Pickl-Herk AM, Blaas D, Oz-Arslan D, Zhu R, Hinterdorfer P, Mavromara P, Georgopoulou U.
    Biochimie; 2009 Jul 20; 91(7):903-15. PubMed ID: 19401214
    [Abstract] [Full Text] [Related]

  • 16. Peptide display on a surface loop of human parvovirus B19 VP2: Assembly and characterization of virus-like particles.
    Santillán-Uribe JS, Valadez-García J, Morán-García Adel C, Santillán-Uribe HC, Bustos-Jaimes I.
    Virus Res; 2015 Apr 02; 201():1-7. PubMed ID: 25701743
    [Abstract] [Full Text] [Related]

  • 17. In vitro encapsulation of heterologous dsDNA into human parvovirus B19 virus-like particles.
    Sánchez-Rodríguez SP, Enrriquez-Avila JV, Soto-Fajardo JM, Peña-Montes C, Bustos-Jaimes I.
    Mol Biotechnol; 2015 Apr 02; 57(4):309-17. PubMed ID: 25389040
    [Abstract] [Full Text] [Related]

  • 18. Human parvovirus B19 serology and avidity using a combination of recombinant antigens enables a differentiated picture of the current state of infection.
    Pfrepper KI, Enders M, Motz M.
    J Vet Med B Infect Dis Vet Public Health; 2005 Apr 02; 52(7-8):362-5. PubMed ID: 16316402
    [Abstract] [Full Text] [Related]

  • 19. Most of the VP1 unique region of B19 parvovirus is on the capsid surface.
    Kawase M, Momoeda M, Young NS, Kajigaya S.
    Virology; 1995 Aug 20; 211(2):359-66. PubMed ID: 7544049
    [Abstract] [Full Text] [Related]

  • 20. Parvovirus B19 viral loads in relation to VP1 and VP2 antibody responses in diagnostic blood samples.
    Beersma MF, Claas EC, Sopaheluakan T, Kroes AC.
    J Clin Virol; 2005 Sep 20; 34(1):71-5. PubMed ID: 15985386
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.